Skip to main content
. 2020 Apr 17;60(1):1–28. doi: 10.1007/s00394-020-02247-8

Table 6.

Study characteristics of acute and chronic human studies assessing the impact of red wine polyphenols on flow mediated dilation measures

Author Year Study design Health status Number of participants Mean age (years) Sex (% F) BMI (kg/m2) Duration (days) Wash out (days) Supplement Dose (mg/day) Flow mediated dilation (∆ %)
Control baseline/final (mean ± SD) Supplement baseline/final (mean ± SD)
Lekakis et al. 2005 P CHD

Control: 15

Supp: 15

61.0 M 28.0 0 NA GE 600 2.75 ± 1.85/2.64 ± 1.8 2.6 ± 1.5/4.52 ± 1.34
Marques et al. 2018 X ED

Control: 24

Supp: 24

54 58 30 0 7 RSV 300 4.1 ± 0.9/2.64 ± 1.8 2.6 ± 1.5/4.52 ± 1.34
Mellen et al. 2010 X Pre-MS

Control: 50

Supp: 50

52.1 50 29.8 28 28 RSV 1300 5.27 ± 0.42/5.18 ± 0.38 5.22 ± 0.32/4.57 ± 0.32
Van Mierlo et al. 2010a X Healthy

Control: 35

Supp: 35

31.4 M 23.2 14 7 GE 1405 5.6 ± 3.6/3.9 ± 2.96 5.6 ± 3.6/3.5 ± 5.66
2010b X Healthy

Control: 35

Supp: 35

31.4 M 23.2 14 7 GSE 2547 5.6 ± 3.6/3.9 ± 2.96 5.6 ± 3.6/4.1 ± 5.66
Wong et al. 2011a X O

Control: NA

Supp: 18

55 27.8 28.7 0 7 RSV 30 NA 4.06 ± 3.39/6.56 ± 4.76
2011b X O

Control: NA

Supp: 18

55 27.8 28.7 0 7 RSV 90 NA 4.06 ± 3.39/6.45 ± 3.61
2011c X O

Control: NA

Supp: 18

55 27.8 28.7 0 7 RSV 270 NA 4.06 ± 3.39/7.73 ± 6.34
Wong et al. 2013 X O

Control: 28

Supp: 28

61 57.1 33.3 42 0 RSV 75 5.83 ± 0.68/5.48 ± 0.69 7.21 ± 0.51/7.42 ± 0.62
Xue et al. 2016 X O

Control: 29

Supp: 29

45 72.4 34.1 56 42 RSV + HESP 210 0.247 ± 0.327/0.267 ± 0.312 0.207 ± 0.195/0.163 ± 0.195

Xue et al., 2016 results are change in diameter not percentage change

X cross-over, P parallel arm, CHD coronary heart disease, MS metabolic syndrome, ED endothelial dysfunction, O obese, RSV resveratrol, GE grape extract, GSE grape seed extract, GADF grape antioxidant dietary fibre, HESP hesperetin